Correspondence

Non-Q-Wave Acute Anterior Myocardial Infarction Associated with 5-Fluorouracil and Cisplatin Chemotherapy

Authors: Mustafa Kemal, Erol MD, Mahmut Acikel, MD, Huseyin Senocak, MD

Abstract

To the Editor:


It is known that the toxic effects of chemotherapeutic agents used in cancer therapy affect mainly the bone marrow and the digestive tract, and to a lesser extent they can cause cardiotoxicity. We report the case of a patient with squamous cell carcinoma of neck who presented with an acute anterior non-Q myocardial infarction after combination chemotherapy with 5-fluorouracil (5-FU) and cisplatin.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Becker K, Erckenbrecht JF, Haussinger D, Frieling T. Cardiotoxicity of the antiproliferative compound fluorouracil. Drugs 1999; 57: 475–484.
 
2. Clavel M, Simeone P, Grivet B. Cardiac toxicity of 5-fluorouracil: Review of the literature, 5 new cases [in French]. Presse Med 1988; 17: 1675–1678.
 
3. Luwaert RJ, Descamps O, Majois F, Chaudron JM, Beauduin M. Coronary artery spasm induced by 5-fluorouracil. Eur Heart J 1991; 12: 468–470.
 
4. Kuzel T, Esparaz B, Green D, Kies M. Thrombogenicity of intravenous 5-fluorouracil alone or in combination with cisplatin. Cancer 1990; 65: 885–889.
 
5. Porta C, Moroni M, Ferrari S, Nastasi G. Endothelin-1 and 5-fluorouracil-induced cardiotoxicity. Neoplasma 1998; 45: 81–82.